Posaconazole 100mgTablet
Anti-Fungal

Posaconazole 100mg

Posaconazole

Extended-spectrum triazole antifungal with superior activity against mucormycosis and aspergillosis compared to other azoles, increasingly preferred as first-line therapy for mucormycosis and prophylaxis in severely immunocompromised patients. Manufactured by Cipla and Natco as delayed-release tablets for oncology and transplant formulary export.

Strengths

100mg

Packing

24 tablets/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Posaconazole 100mg (delayed-release)
Dosage Form
Tablet
Available Strengths
100mg
Packing
24 tablets/bottle
Route of Administration
Oral, with food
Dosage
Prophylaxis: 300mg BID on day 1, then 300mg once daily; Treatment: 300mg BID loading, then 300mg daily
Indications
Prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients, oropharyngeal candidiasis, mucormycosis
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 25°C
Shelf Life
36 months
Side Effects
Nausea, diarrhea, vomiting, headache, abdominal pain, elevated liver enzymes, QTc prolongation, hypokalemia
Precautions
QTc prolongation risk; hepatotoxicity monitoring; extensive drug interactions; delayed-release tablets preferred over oral suspension for bioavailability; avoid with sirolimus and ergot alkaloids

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Posaconazole 100mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote